Unknown

Dataset Information

0

Chemotherapy responsiveness in a patient with multiply relapsed ameloblastic fibro-odontosarcoma of the maxilla.


ABSTRACT: Ameloblastic fibro-odontosarcoma (AFOS) is an extremely rare malignant odontogenic tumor. Complete surgical excision is the treatment of choice. Deaths due to disease recurrence and/or progression are documented. Here, we report the case of a 15-year-old female with multiple recurrent AFOS. She responded to chemotherapy with ifosfamide and doxorubicin consolidated by stereotactic reirradiation using cyberknife and remained in complete remission 14 months from the end of reirradiation therapy. Chemotherapy with ifosfamide and doxorubicin should be considered in advanced cases of AFOS.

SUBMITTER: Gatz SA 

PROVIDER: S-EPMC4737202 | BioStudies | 2015-01-01

SECONDARY ACCESSION(S): 10.1002/pbc.25627

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5842271 | BioStudies
2016-01-01 | S-EPMC4779061 | BioStudies
2011-01-01 | S-EPMC3003614 | BioStudies
1000-01-01 | S-EPMC4915543 | BioStudies
2020-01-01 | S-EPMC6969439 | BioStudies
2015-01-01 | S-EPMC4789878 | BioStudies
2020-01-01 | S-EPMC7488346 | BioStudies
2018-01-01 | S-EPMC6209090 | BioStudies
2012-01-01 | S-EPMC3494838 | BioStudies
1000-01-01 | S-EPMC3765173 | BioStudies